OCULAR MELANOMA
Clinical trials for OCULAR MELANOMA explained in plain language.
Never miss a new study
Get alerted when new OCULAR MELANOMA trials appear
Sign up with your email to follow new studies for OCULAR MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to fight rare eye cancer
Disease control Recruiting nowThis study tests two drugs, olaparib and pembrolizumab, together in people with advanced uveal melanoma, a rare eye cancer that has spread. The goal is to see if the combination can shrink tumors or slow the cancer's growth. About 37 adults will take part in this phase 2 trial.
Matched conditions: OCULAR MELANOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
New combo therapy aims to supercharge immune cells against hard-to-treat melanoma
Disease control Recruiting nowThis study tests a new drug (IOV-3001) that boosts the immune system, given together with a personalized cell therapy (lifileucel) in people with advanced melanoma that has stopped responding to standard treatments. About 42 adults with unresectable or metastatic melanoma will ta…
Matched conditions: OCULAR MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:11 UTC
-
Light-Activated drug could halt rare eye cancer growth
Disease control Recruiting nowThis study tests a new drug called belzupacap sarotalocan (AU-011) for people with a rare eye cancer (choroidal melanoma) or suspicious spots that could turn into cancer. The drug is activated by a laser to target and destroy cancer cells. About 100 participants will receive eith…
Matched conditions: OCULAR MELANOMA
Phase: PHASE3 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
How does eye cancer affect daily life? new study aims to find out
Knowledge-focused Recruiting nowThis study tracks how choroidal melanoma and its treatment affect patients' quality of life. About 15 people already in a larger Phase 3 trial will answer questionnaires about their well-being over two years. No new drugs or procedures are tested—only information is collected.
Matched conditions: OCULAR MELANOMA
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated May 26, 2026 04:12 UTC